Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T L Stanghellini

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Gene Therapy|May 29, 2010
Progress and prospects: graft-versus-host diseaseS Mastaglio, M T L Stanghellini, C Bordignon, et al.
Bone Marrow Transplantation|June 4, 2015
Haploidentical HSCT: a 15-year experience at San RaffaeleC Bonini, J Peccatori, M T L Stanghellini, et al.
Bone Marrow Transplantation|June 16, 2015
Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overallM Noviello, A Forcina, V Veronica, et al.
Leukemia|June 5, 2014
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donorsJ Peccatori, A Forcina, D Clerici, et al.
Bone Marrow Transplantation|October 31, 2017
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)L Giaccone, G Mancini, N Mordini, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Gene Therapy|May 29, 2010
Progress and prospects: graft-versus-host diseaseS Mastaglio, M T L Stanghellini, C Bordignon, et al.
Bone Marrow Transplantation|June 4, 2015
Haploidentical HSCT: a 15-year experience at San RaffaeleC Bonini, J Peccatori, M T L Stanghellini, et al.
Bone Marrow Transplantation|June 16, 2015
Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overallM Noviello, A Forcina, V Veronica, et al.
Leukemia|June 5, 2014
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donorsJ Peccatori, A Forcina, D Clerici, et al.
Bone Marrow Transplantation|October 31, 2017
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)L Giaccone, G Mancini, N Mordini, et al.
Pageof 1